Wednesday, May 21, 2025 7:30:27 PM
💥“The Company’s +PlusCBD TM branded PRODUCTS are sold at select retail locations throughout the U.S. and are the TOP- SELLING BRANDS of hemp extracts in the natural products market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry.”💥
+PlusCBD TM Per Wellness treats are crafted with the utmost care and supported by extensive research, and are now further validated by a landmark safety study backed by the National Animal Supplement (NASC)💥. NASC is the leading trade association advocating for the health and wellness of companion animals that are given health supplements by their owners.
💥 https://ir.cvsciences.com/press-releases/detail/221/cv-sciences-inc-expands-pluscbd-pet-product-offerings 💥
💥HERE IS WHAT HAPPENED AGAIN TODAY TO OTHER COMPANIES 💥
https://www.petfoodindustry.com/cbd-treats-for-dogs-and-cats/news/15746700/fda-issues-warning-letters-to-cbd-and-mushroom-pet-supplement-makers
+PlusCBD TM Per Wellness treats are crafted with the utmost care and supported by extensive research, and are now further validated by a landmark safety study backed by the National Animal Supplement (NASC)💥. NASC is the leading trade association advocating for the health and wellness of companion animals that are given health supplements by their owners.
💥 https://ir.cvsciences.com/press-releases/detail/221/cv-sciences-inc-expands-pluscbd-pet-product-offerings 💥
💥HERE IS WHAT HAPPENED AGAIN TODAY TO OTHER COMPANIES 💥
https://www.petfoodindustry.com/cbd-treats-for-dogs-and-cats/news/15746700/fda-issues-warning-letters-to-cbd-and-mushroom-pet-supplement-makers
Bullish
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
